Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical [Yahoo! Finance]
Tevogen Bio Holdings Inc. (TVGN)
Company Research
Source: Yahoo! Finance
announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent (“LoI”) to evaluate a potential transaction with Apozeal Pharmaceutical Inc. (“Apozeal”), a pharmaceutical company focused on the development and manufacturing of high-quality, cost-effective medicines. The proposed transaction represents a strategic step in advancing Tevogen Generics, established to support domestic pharmaceutical manufacturing and enhance affordability and national supply chain resilience. If consummated, the potential acquisition of Apozeal could provide Tevogen with an established generics platform, including: 11 FDA-approved Abbreviated New Drug Application (ANDA) products for the U.S. market Multiple ANDAs currently filed with the U.S. Food and Drug Administration awaiting approval Additional generic products in development Dr. Ryan Saadi, Founder and Chief Executive Officer of Tevogen, stated, “Tevogen Generics was launched with the objective of supporting pharm
Show less
Read more
Impact Snapshot
Event Time:
TVGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TVGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TVGN alerts
High impacting Tevogen Bio Holdings Inc. news events
Weekly update
A roundup of the hottest topics
TVGN
News
- Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal PharmaceuticalGlobeNewswire
- Tevogen Bio (TVGN) was downgraded by D. Boral Capital from "buy" to "hold".MarketBeat
- Tevogen Announces Reverse Stock SplitGlobeNewswire
- Tevogen Bio (TVGN) had its price target lowered by D. Boral Capital from $5.00 to $2.00. They now have a "buy" rating on the stock.MarketBeat
- Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research OrganizationGlobeNewswire
TVGN
Sec Filings
- 3/4/26 - Form 424B3
- 3/4/26 - Form 8-K
- 2/26/26 - Form 424B3
- TVGN's page on the SEC website